NCT06113848View on ClinicalTrials.gov

Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy

PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 7, 2023

Primary Completion Date

September 7, 2024

Study Completion Date

September 7, 2024

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Intra-Arterial TNK and Albumin

The study population was divided into four groups, one of which had intra-arterial TNK and albumin.

DRUG

Intra-Arterial TNK

The study population was divided into four groups, one of which had intra-arterial TNK .

DRUG

Intra-Arterial Albumin

The study population was divided into four groups, one of which had intra-arterial albumin.

OTHER

sham

The study population was divided into four groups, one of which had no intra-arterial TNK and albumin.

Trial Locations (1)

300222

RECRUITING

Tianjin Huanhu Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Huanhu Hospital

OTHER

NCT06113848 - Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy | Biotech Hunter | Biotech Hunter